Vas Narasimhan Compensation Performance against incentive targets combined with base salary and other benefits and pension resulted in 2022 total realized compensation for the CEO of CHF 8 452 176 This is a reduction of 24 7 compared to 2021 driven mainly by lower payout of the Long Term Performance Plan LTPP More details on CEO performance and compensation are
Novarti s Chief Executive Officer Vas Narasimhan took home 12 16 million in total compensation for 2021 In 2020 his total compensation was valued at about 11 24 million Compensation included base salary and stocks pension and additional expenses Novartis group sales took a hit from COVID 19 and so did CEO Vas Narasimhan s 2020 pay The Swiss pharma handed its CEO a pay package worth CHF10 38 million 11 61 million for 2020 down
Vas Narasimhan Compensation
Vas Narasimhan Compensation
https://static01.nyt.com/images/2019/08/04/business/04CORNEROFFICE-01/merlin_155269668_18f42763-08de-4267-a2b3-77e1cfd4d732-articleLarge.jpg?quality=75&auto=webp&disable=upscale
Vas Narasimhan Of Novartis We Are Not At All Prepared For A Pandemic
https://static01.nyt.com/images/2019/08/04/business/04CORNEROFFICE-01/04CORNEROFFICE-01-videoSixteenByNineJumbo1600.jpg
Novartis CEO Vas Narasimhan We Will Have To Live With The Virus For A
https://naxos-cdn01.gruppocdt.ch/cdt/stories/historical/960x640/a443d08f-8ad2-46d0-9045-1fb62689bb07.jpg
Vas Narasimhan received total compensation in 2021 of CHF11 2M 12 1M That was composed of CHF 2 2M in pay The rest of his compensation according to the company s annual report was For his part Novartis CEO Vas Narasimhan in his fourth year as chief exec scored a pay package worth 11 22 million Swiss francs 12 18 million About 2 2 million Swiss francs came from
Total realized compensation Vasant Narasimhan 1 769 200 442 132 2 657 267 6 356 128 11 224 727 1 The shown amount represents the underlying share value of the total number of shares vested including dividend equivalents of CHF 581 198 and Alcon Keep Whole awards of 612 696 to the CEO for the 2019 2021 LTPP performance cycle Novartis CEO is Vas Narasimhan appointed in Feb 2018 has a tenure of 5 92 years total yearly compensation is 11 85M comprised of 16 3 salary and 83 7 bonuses including company stock and options directly owns 0 015 of the company s shares worth CHF27 18M
More picture related to Vas Narasimhan Compensation
Novartis CEO Vas Narasimhan Wickelt Basel Um Den Finger Ein Lehrst ck
https://tageswoche.ch/wp-content/uploads/2018/09/2404.jpg
Vasant Vas Narasimhan African Parks
https://www.africanparks.org/sites/default/files/teaser_image/2022-12/Vas-cropped.jpg
Novartis CEO Vas Narasimhan On The Timeline For Coronavirus Treatments
https://image.cnbcfm.com/api/v1/image/105709535-1548869591873rts2cvyt.jpg?v=1548869620
Vasant NarasimhanCHF10 381 792 in total compensation as Chief Executive Officer at Novartis in 2020 CHF1 743 750 was received as Total Cash CHF8 349 099 was received as Equity and CHF288 943 was received as Pension and other forms of compensation This information is derived from proxy statements filed for the 2020 fiscal year Exclusive How Novartis s CEO Learned From His Mistakes and Got Help From an Unlikely Quarter After some deals and drug launches disappointed Vas Narasimhan heard from investors and hired an
Under the guidance of CEO Vas Narasimhan Novartis AG VTX NOVN has performed reasonably well recently This is something shareholders will keep in mind as they cast their votes on company Vas Narasimhan is Chief Executive Officer at Novartis AG See Vas Narasimhan s compensation career history education memberships
Kritik An Novartis Chef Vas Narasimhan W chst Muss Er Bald Gehen Blick
https://img.blick.ch/incoming/15827909-v2-thm-9974.jpg?imwidth=2000&ratio=16_9&x=0&y=118&width=6720&height=3784
Directorul Novartis Un Vaccin mpotriva Covid 19 Abia Peste Doi Ani
https://newsmaker.ro/wp-content/uploads/2020/05/Vas-Narasimhan-1024x575.jpg
Vas Narasimhan Compensation - Total realized compensation Vasant Narasimhan 1 769 200 442 132 2 657 267 6 356 128 11 224 727 1 The shown amount represents the underlying share value of the total number of shares vested including dividend equivalents of CHF 581 198 and Alcon Keep Whole awards of 612 696 to the CEO for the 2019 2021 LTPP performance cycle